Isracann Biosciences Inc.

Isracann Biosciences Inc.

ISCNF - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$1.76K
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Isracann Biosciences Inc.Isracann Biosciences Inc.-0.5--3543%--

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$1,760.00
Enterprise Value$-196,294.00
Earnings per Share$-0.03
Beta0.19
Outstanding Shares158,455,213

Return

Return on Equity-3542.57%ROE
Return on Assets-112.40%
Return on Invested Capital-150.84%

Valuation & Multiples

P/E Ratio-0.47P/E Ratio
PEG1.45PEG
Price to Sales-Price to Sales
Price to Book Ratio-Price to Book Ratio
Enterprise Value to Revenue-
Enterprise Value to EBIT0.04
Enterprise Value to Net Income0
Total Debt to Enterprise0
Debt to Equity0Debt to Equity

Revenue Sources

No data

Institutional Sentiment (Put/Call)

No data available for the latest quarter.

Institutional Ownership

No data available for the latest quarter.

About Isracann Biosciences Inc.

0
CEO: Ajay Singh Kaila

Isracann Biosciences Inc., operating with its subsidiary companies, focuses on the growth and supply of medical-grade cannabis throughout Israel. The firm also dedicates resources to establishing new cultivation infrastructure. Additiona...